Cargando…

Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers

BACKGROUND: Cancer, as a complex, heterogeneous disease, is currently affecting millions of people worldwide. Even if the most common traditional treatments, namely, chemotherapy (CTx) and radiotherapy (RTx), have been so far effective in some conditions, there is still a dire need for novel, innova...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owliaee, Iman, khaledian, Mehran, Boroujeni, Armin Khaghani, Shojaeian, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621078/ https://www.ncbi.nlm.nih.gov/pubmed/37915098 http://dx.doi.org/10.1186/s13027-023-00549-0

Ejemplares similares

Oncoviruses and Pathogenic MicroRNAs in Humans
por: Fujii, Yoichi Robertus
Publicado: (2009)

The Role of Deubiquitinases in Oncovirus and Host Interactions
por: Li, Yueshuo, et al.
Publicado: (2019)

Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review
por: de Almeida, Nathália Alves Araújo, et al.
Publicado: (2021)

Oncoviruses and melanomas: A retrospective study and literature review
por: Ciccarese, Giulia, et al.
Publicado: (2022)

The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development
por: Tornesello, Maria Lina, et al.
Publicado: (2022)

Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy
por: Nečasová, Ivona, et al.
Publicado: (2022)

Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses
por: Mahmoudvand, Shahab, et al.
Publicado: (2022)

Oncoviruses Can Drive Cancer by Rewiring Signaling Pathways Through Interface Mimicry
por: Guven-Maiorov, Emine, et al.
Publicado: (2019)

HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers
por: Proulx, Jessica, et al.
Publicado: (2022)

Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy
por: Aghamajidi, Azin, et al.
Publicado: (2022)

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2018)

Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells
por: Davis, David A., et al.
Publicado: (2018)

Polyploid Giant Cancer Cells, a Hallmark of Oncoviruses and a New Therapeutic Challenge
por: Herbein, Georges, et al.
Publicado: (2020)

A Novel Silicon Platform for Selective Isolation, Quantification, and Molecular Analysis of Small Extracellular Vesicles
por: Leonardi, Antonio Alessio, et al.
Publicado: (2021)

A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties
por: Dooley, Kevin, et al.
Publicado: (2021)

Contribution of Epstein–Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses
por: Dorothea, Mike, et al.
Publicado: (2023)

Extracellular Vesicle Therapy for Type 1 Diabetes
por: Soltani, Setareh, et al.
Publicado: (2022)

Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
por: Liu, Xinyi, et al.
Publicado: (2023)

Strategies for Engineering of Extracellular Vesicles
por: Danilushkina, Anna A., et al.
Publicado: (2023)

Small extracellular vesicles as a multicomponent biomarker platform in urinary tract carcinomas
por: K, Szeliski, et al.
Publicado: (2022)

Engineered small extracellular vesicles as a versatile platform to efficiently load ferulic acid via an “esterase-responsive active loading” strategy
por: Man, Fulong, et al.
Publicado: (2022)

Identification of Novel Senescent Markers in Small Extracellular Vesicles
por: Misawa, Tomoka, et al.
Publicado: (2023)

A magneto-activated nanoscale cytometry platform for molecular profiling of small extracellular vesicles
por: Chen, Kangfu, et al.
Publicado: (2023)

Progress in Isolation and Molecular Profiling of Small Extracellular Vesicles via Bead-Assisted Platforms
por: Kozhevnikova, Daria, et al.
Publicado: (2023)

Therapeutic Potential of Engineered Extracellular Vesicles
por: Mentkowski, Kyle I., et al.
Publicado: (2018)

Emerging technologies for engineering of extracellular vesicles
por: Zhou, Xin, et al.
Publicado: (2023)

A novel multiplex bead-based platform highlights the diversity of extracellular vesicles
por: Koliha, Nina, et al.
Publicado: (2016)

Small extracellular vesicles in cancer
por: Abhange, Komal, et al.
Publicado: (2021)

In vitro susceptibilities of normal human skin fibroblasts to oncoviruses, and the decreased susceptibility to HSV of fibroblasts from untreated Hodgkin's patients.
por: Ebbesen, P., et al.
Publicado: (1981)

Extracellular vesicles: An emerging platform in gram-positive bacteria
por: Bose, Swagata, et al.
Publicado: (2020)

Cryptococcus extracellular vesicles properties and their use as vaccine platforms
por: Rizzo, Juliana, et al.
Publicado: (2021)

Small Extracellular Vesicles: A Novel Avenue for Cancer Management
por: Gao, Yanan, et al.
Publicado: (2021)

Engineering Extracellular Vesicles as Nanotherapeutics for Regenerative Medicine
por: Ramasubramanian, Lalithasri, et al.
Publicado: (2019)

Native and engineered extracellular vesicles for wound healing
por: Lu, Shengli, et al.
Publicado: (2022)

Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy
por: Johnson, Vinith, et al.
Publicado: (2023)

Editorial: Engineered extracellular vesicles for tissue repairing
por: Yu, Shiyi, et al.
Publicado: (2023)

Engineered extracellular vesicles for ischemic stroke treatment
por: Ruan, Huitong, et al.
Publicado: (2023)

Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLL
por: Gärtner, Kathrin, et al.
Publicado: (2019)

Engineered Cas9 extracellular vesicles as a novel gene editing tool
por: Osteikoetxea, Xabier, et al.
Publicado: (2022)

Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus
por: Ghobadi, Mohadeseh Zarei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5alkc0p02i796jgtmm2a38rvu3